about
Carbohydrate PEGylation, an approach to improve pharmacological potencyDevelopment of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In VivoPeptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancerSpecies differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirusBolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola VaccineA cholesterol tag at the N terminus of the relatively broad-spectrum fusion inhibitory peptide targets an earlier stage of fusion glycoprotein activation and increases the peptide's antiviral potency in vivo.Improving adenovirus based gene transfer: strategies to accomplish immune evasion.Concepts and practices used to develop functional PLGA-based nanoparticulate systemsThe evolution of adenoviral vectors through genetic and chemical surface modifications.Site-Specific PEGylated Adeno-Associated Viruses with Increased Serum Stability and Reduced Immunogenicity.Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma.The novel functional nucleic acid iRed effectively regulates target genes following cytoplasmic delivery by faint electric treatment.Beyond Gene Delivery: Strategies to Engineer the Surfaces of Viral Vectors.Photo-induced conjugation of tetrazoles to modified and native proteins.Designer Oncolytic Adenovirus: Coming of Age.
P2860
Q27000494-95D48681-02AA-4D2D-B6F9-2FB26FF80434Q28534124-6D061DFA-4FCF-455B-BDEB-2378991FA1EAQ33584756-D3D35BFF-5395-4F2B-B0F2-0F653DE63461Q34975214-FFF8EED1-CFF7-4A4A-91FF-BD2A18704DECQ35917496-38D0595B-CC88-47B2-93EF-39BB236BDCEAQ37123271-2E4647F8-A1AB-4C1E-BDE8-D4911EFD2F7FQ37945219-42F30BB1-D0C8-42F7-B79D-6303A87A8757Q38086377-2EDA59ED-A1D7-4134-8BF6-D4924A701096Q38189250-0441C3E0-7D71-4E2A-94BC-E6B290A56400Q38684383-CAD293E5-9074-40EB-803E-40F4B187AA66Q40438006-2B1F4A5B-4BF7-46B9-93EC-44D1DB270352Q41872943-9C7E40F2-A1A0-485A-8F3C-BE468E4CF827Q51857382-7D1F267D-A733-48F6-9207-EC084AB493E4Q53026780-7B9D9AFD-4C44-4AD5-B324-8491CC653E14Q55467684-383FF900-9277-4451-A858-82D4432B6499
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
PEGylated Adenoviruses: From Mice to Monkeys
@ast
PEGylated Adenoviruses: From Mice to Monkeys
@en
PEGylated Adenoviruses: From Mice to Monkeys
@nl
type
label
PEGylated Adenoviruses: From Mice to Monkeys
@ast
PEGylated Adenoviruses: From Mice to Monkeys
@en
PEGylated Adenoviruses: From Mice to Monkeys
@nl
prefLabel
PEGylated Adenoviruses: From Mice to Monkeys
@ast
PEGylated Adenoviruses: From Mice to Monkeys
@en
PEGylated Adenoviruses: From Mice to Monkeys
@nl
P2860
P3181
P356
P1433
P1476
PEGylated Adenoviruses: From Mice to Monkeys
@en
P2093
Maria A Croyle
Piyanuch Wonganan
P2860
P304
P3181
P356
10.3390/V2020468
P407
P577
2010-02-01T00:00:00Z